Compounding Pharmacy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Compounding Pharmacy Market is segmented by Therapeutic Area (Pain Management, Hormone Replacement, Dermal Disorders, Nutritional Supplements, Other Therapeutic Areas), Route of Administration (Oral, Topical, Parenteral, Other Routes of Administration), End User (Humans, Veterinary) and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America).

Compounding Pharmacy Market Size

Single User License
Team License
Corporate License
Book before:
Compounding Pharmacy Market Summary
share button
Study Period 2019 - 2029
Market Size (2024) USD 14.31 Billion
Market Size (2029) USD 18.86 Billion
CAGR (2024 - 2029) 5.68 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Compounding Pharmacy Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

OFF

Team License

OFF

Corporate License

OFF
Book before:

Compounding Pharmacy Market Analysis

The Compounding Pharmacy Market size is estimated at USD 14.31 billion in 2024, and is expected to reach USD 18.86 billion by 2029, growing at a CAGR of 5.68% during the forecast period (2024-2029).

The COVID-19 pandemic had a significant impact on the compounding pharmacy market. Several guidelines were issued by drug regulatory authorities, such as the United States Food and Drug Administration (US FDA), regarding compounded drug use for COVID-19 patients. For instance, as per the data from the US FDA published in January 2023, it was found that the FDA advised states and drug compounders on concerns relating to drug compounding during the COVID-19 pandemic. The agency's recommendations aim to safeguard patients from harmful, ineffective, and unsatisfactory compounded medications while maintaining patient access. The data further stated that stringent regulation was followed for compounded drugs during the pandemic to avoid any complications associated with such drugs. Therefore, the pandemic had a considerable impact on the market studied. However, with the rising need for personalized medicine and the growing aging population, it is believed that the market is likely to witness strong growth in the coming years.

The key factors responsible for the market growth include increasing demand for personalized medicine, shortage of drugs, and a rising geriatric population.

The growing geriatric population is one of the leading factors for market growth. For instance, according to the report from the United Nations published in January 2023, the number of people aged over 65 or older is believed to double in the next three decades. In contrast, it is expected to reach around 1.6 billion by the year 2050. The senior population is more prone to suffer from chronic, complex, and multiple diseases simultaneously, such as cardiovascular diseases, cancer, and other chronic diseases that need personalized treatment. Hence, demand for compounding pharmacies is expected to increase to treat complex diseases in the geriatric population, driving market growth over the forecast period.

Additionally, the shortage of drugs in several countries is further likely to accelerate the compounding pharmacy market growth. For instance, according to the United States Food and Drug Administration (USFDA) data published in August 2021, the United States has faced a drug shortage problem for the last few years. The COVID-19 outbreak further worsened this scenario in the country. This shortage was due to supply chain disruption, delays & discontinuation in the manufacturing processes, quality issues, and difficulties in purchasing raw materials. Hence, drug shortage further creates opportunities for compounding pharmacies, propelling the market’s growth during the forecast period.

However, the need for skilled compounding pharmacists is expected to hinder market growth in the coming years.

Compounding Pharmacy Market Trends

Pain Management Segment is Expected to Dominate the Market During the Forecast Period.

The pain management segment is expected to account for the largest share of the market owing to the large patient base suffering from chronic pain from various diseases. Increasing accidental cases, high burden of cancer, and chronic pain cases are key factors responsible for the growth of the pain management market. For instance, according to the data published by the Health Economists in September 2021, Chronic pain costs about USD 635 billion yearly to the United States, which is greater than the annual costs of diabetes, cancer, and heart diseases. Compounding pharmacies provide drugs for effective pain management tailored for specific patients. Thus, chronic pain management is expected to contribute to the market's growth during the forecast period.

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), anticonvulsants, antidepressants, topical analgesics, and opioids are the major classes of drugs that doctors prescribe for chronic pain management. Nonsteroidal anti-inflammatory drugs are available by prescription to relieve fever and pain. However, certain side effects are associated with these medications, including stomach irritation, unpleasant side effects, and unwanted flavor/route of administration. Compounding pharmacies provide alternate methods to ease consumption and cope with the side effects. Such an advantage of compounding pharmacy is expected to accelerate market growth.

Compounding Pharmacy Market: Estimated Number of New Cancer Cases (in Million), By Gender, United States, 2023

North America is Expected to Hold Major Share in the Market during the Forecast Period

The compounding pharmacy industry in North America is expected to hold a significant market share during the forecast period. The presence of several compounding pharmacies, high adoption among people, and scarcity of many drugs are key factors for market growth. According to the statistics published by the International Academy of Compounding Pharmacists (IACP) in October 2021, about 56,000 compounding pharmacies were operating in the United States, of which 7,500 pharmacies provide advanced compounding services.

Several organizations are interested in the compounding pharmacy business across the United States, which is believed to contribute to the market growth. For instance, in March 2021, Osceola Capital, a lower middle-market private equity firm, announced the formation of Revelation Pharma Corp. to pursue investments and partnerships across the pharmacy compounding market in partnership with industry executives.

Similarly, in August 2021, Empower Pharmacy, a premier compounding pharmacy and FDA-registered outsourcing facility, announced its new branch opening in Houston, United States. Approximately USD 55 million was spent on this facility to enhance access to affordable and innovative pharmaceutical solutions in the North American region. Therefore, owing to the developments mentioned above in the compounding pharmacy business, the market studied is believed to witness strong growth in the region.

Compounding Pharmacy Market - Growth Rate by Region

Compounding Pharmacy Industry Overview

The compounding pharmacy market is moderately consolidated. B. Braun, Athenex Pharma Solutions, Fresenius Kabi, Clinigen Group PLC, Dougherty's Pharmacy, Inc., Lorraine's Pharmacy, Nephron Pharmaceuticals Corporation, Rx3 Compounding Pharmacy, Institutional Pharmacy Solutions, Mcguff compounding pharmacy services, Pencol Compounding Pharmacy, ITC Compounding Pharmacy, and Valor Compounding Pharmacy are some of the key compounding pharmacies in the market.

Compounding Pharmacy Market Leaders

  1. B. Braun Medical Inc.

  2. Fresenius Kabi

  3. Wedgewood Pharmacy

  4. Clinigen Group PLC

  5. Fagron NV

*Disclaimer: Major Players sorted in no particular order

Compounding Pharmacy Market Concentration
bookmark Need More Details on Market Players and Competitors?
Download PDF

Compounding Pharmacy Market News

  • July 2022: Fagron, the leading global player in pharmaceutical compounding, acquired a 503B outsourcing facility from Fresenius Kabi in Boston. With this acquisition, Fagron expanded its United States sterile compounding footprint.
  • June 2022: Osceola Capital, a private equity firm, announced the eighth addition to the Revelation Pharma Corporation platform by purchasing Wedgewood Pharmacy’s human health book of business. Wedgewood Pharmacy operates compounding pharmacies that offer sterile and non-sterile compounded medications for animal patients in 50 states.

Compounding Pharmacy Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Demand of Personalized Medicine

      2. 4.2.2 Shortage of Drugs

      3. 4.2.3 Rising Geriatric Population

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Skilled Compounding Pharmacists

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Buyers/Consumers

      2. 4.4.2 Bargaining Power of Suppliers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value – USD)

    1. 5.1 By Therapeutic Area

      1. 5.1.1 Pain Management

      2. 5.1.2 Hormone Replacement

      3. 5.1.3 Dermal Disorders

      4. 5.1.4 Nutritional Supplements

      5. 5.1.5 Other Therapeutic Areas

    2. 5.2 By Route of Administration

      1. 5.2.1 Oral

      2. 5.2.2 Topical

      3. 5.2.3 Parenteral

      4. 5.2.4 Other Route of Administrations

    3. 5.3 By End-User

      1. 5.3.1 Humans

      2. 5.3.2 Veterinary

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 B. Braun Medical Inc.

      2. 6.1.2 Fagron NV

      3. 6.1.3 Fresenius Kabi

      4. 6.1.4 Wedgewood Pharmacy

      5. 6.1.5 Clinigen Group PLC

      6. 6.1.6 Dougherty's Pharmacy, Inc.

      7. 6.1.7 Lorraine's Pharmacy

      8. 6.1.8 Rx3 Compounding Pharmacy

      9. 6.1.9 Institutional Pharmacy Solutions

      10. 6.1.10 Mcguff compounding pharmacy services

      11. 6.1.11 Pencol Compounding Pharmacy

      12. 6.1.12 ITC Compounding Pharmacy

      13. 6.1.13 Valor Compounding Pharmacy, Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
bookmark You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Compounding Pharmacy Industry Segmentation

As per the scope of this report, a compounding pharmacy is a formulation of personalized or custom pharmaceutical products that are unique to the patient's needs and generally not available commercially. The Compounding Pharmacy Market is segmented by Therapeutic Area (Pain Management, Hormone Replacement, Dermal Disorders, Nutritional Supplements, Other Therapeutic Areas), Route of Administration (Oral, Topical, Parenteral, Other Routes of Administration), End User (Humans, Veterinary) and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD) for the above segments. 

By Therapeutic Area
Pain Management
Hormone Replacement
Dermal Disorders
Nutritional Supplements
Other Therapeutic Areas
By Route of Administration
Oral
Topical
Parenteral
Other Route of Administrations
By End-User
Humans
Veterinary
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
customize-icon Need A Different Region Or Segment?
Customize Now

Compounding Pharmacy Market Research FAQs

The Compounding Pharmacy Market size is expected to reach USD 14.31 billion in 2024 and grow at a CAGR of 5.68% to reach USD 18.86 billion by 2029.

In 2024, the Compounding Pharmacy Market size is expected to reach USD 14.31 billion.

B. Braun Medical Inc. , Fresenius Kabi , Wedgewood Pharmacy , Clinigen Group PLC and Fagron NV are the major companies operating in the Compounding Pharmacy Market.

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Compounding Pharmacy Market.

In 2023, the Compounding Pharmacy Market size was estimated at USD 13.54 billion. The report covers the Compounding Pharmacy Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Compounding Pharmacy Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Compounding Pharmacy Industry Report

Statistics for the 2023 Compounding Pharmacy market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Compounding Pharmacy analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Compounding Pharmacy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)